QTRX Quanterix Corporation - Common Stock
NASDAQ · Life Sciences Tools & Services · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 10, 2026
$3,64
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$2,15minimo 52 sett.
$8,66massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$172M
P/E (TTM)
-1.4
EPS (TTM)
$-2.62
Ricavi (TTM)
$153M
i tuoi badge
Intervallo 52 sett.
$2–$9
Rating Analisti
HOLD
Prezzo Obiettivo
$3
P/E
-1.4
ROE
-46.5%
Margine di Profitto Netto
-80.2%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
QTRX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$3.64
Capitalizzazione di Mercato (MRQ)
$172M
P/E (TTM)
-1.4
EPS (TTM)
$-2.62
Ricavi (TTM)
$153M
ROE (TTM)
-46.5%
Intervallo 52 sett.
$2–$9
QTRX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Informazioni su Quanterix Corporation - Common Stock Panoramica della società da Wikipedia
settoreHealthcare
industriaLife Sciences Tools & Services
dipendenti450
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$139M2022-12-31 → 2025-12-31
EPS$-2.512022-12-31 → 2025-12-31
Flusso di cassa libero$-80M2022-12-31 → 2025-12-31
Margine netto-80.2%2022-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | QTRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.4media 5 anni ≈-16.5 | ≈-16.5 | · | · | |
| P/S (TTM) | 1.1 | · | 4.6 | Sottovalutato | |
| P/B (MRQ) | 0.7 | · | 1.3 | Sottovalutato | |
| Prezzo / FCF (TTM) | -2.1 | · | · | · | |
| Prezzo / Flusso di cassa (TTM) | -2.1 | · | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 1.3media 5 anni ≈2.1 | ≈2.1 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | QTRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine lordo (TTM) | 42.7% | · | 48.5% | Debole | |
| Margine Operativo (TTM) | -99.6% | · | -126.3% | Debole | |
| Margine EBITDA (TTM) | -84.4% | · | -126.3% | Debole | |
| Margine ante imposte (TTM) | -81.7% | · | -106.6% | Debole | |
| Margine di Profitto Netto (TTM) | -80.2% | · | -127.6% | Debole | |
| ROA (TTM) | -35.4% | · | -20.2% | Debole | |
| ROE (TTM) | -46.5% | · | -26.9% | Debole | |
| ROIC | -40.5% | · | -30.2% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | QTRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 3.4 | · | 6.8 | Bassa liquidità | |
| Quick Ratio | 0.8 | · | 2.1 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | QTRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 1.1%media 5 anni ≈9.8% | ≈9.8% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 9.6%media 5 anni ≈9.8% | ≈9.8% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 10.0% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | QTRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.3 | · | 0.4 | In linea | |
| Inventory Turnover (Rotazione delle scorte) | 1.7 | · | 2.1 | Debole | |
| Receivables Turnover (Rotazione dei crediti) | 4.5 | · | 5.2 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$308.7K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-30.0%
Prossimo report
Nov 09, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 5, 2026 | $-1.04 | $-0.47 | -121.7% |
| 31 Marzo 2026 | Mag 12, 2026 | $-0.37 | $-0.55 | 33.2% |
| 31 Dicembre 2025 | $-0.49 | $-0.46 | -6.8% | |
| 30 Settembre 2025 | $-0.73 | $-0.54 | -35.0% | |
| 30 Giugno 2025 | $-0.57 | $-0.37 | -55.2% | |
| 31 Marzo 2025 | $-0.42 | $-0.45 | 5.7% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $139M | $137M | $122M | $106M | $111M | $86M | $57M | $38M | $23M | |
| Cost of Revenue | $74M | $54M | $48M | $60M | $46M | $38M | $30M | $20M | $13M | |
| Gross Profit | $65M | $83M | $74M | $45M | $65M | $48M | $27M | $18M | $10M | |
| R&D Expense | $36M | $31M | $26M | $27M | $28M | $20M | $16M | $16M | $16M | |
| SG&A Expense | $138M | $102M | $89M | $92M | $93M | $60M | $52M | $34M | $20M | |
| Operating Expenses | $191M | $136M | $120M | $150M | $121M | $80M | $68M | $49M | $36M | |
| Operating Income | $-126M | $-53M | $-46M | $-104M | $-57M | $-32M | $-42M | $-32M | $-26M | |
| Other Non-op | $157.0K | $-136.0K | $3M | $-277.0K | $1M | $-49.0K | $-10.0K | $-7.0K | $-63.0K | |
| Pretax Income | $-112M | $-38M | $-28M | $-99M | $-56M | $-32M | $-41M | $-32M | $-27M | |
| Income Tax | $-5M | $434.0K | $719.0K | $164.0K | $-36.0K | $-376.0K | $-187.0K | $25.0K | $0 | |
| Net Income | $-107M | $-39M | $-28M | $-100M | $-56M | $-32M | $-41M | $-32M | $-27M | |
| EPS (Basic) | $-2.51 | $-1.00 | $-0.75 | $-2.69 | $-1.54 | $-1.07 | $-1.63 | · | · | |
| EPS (Diluted) | $-2.51 | $-1.00 | $-0.75 | $-2.69 | $-1.54 | $-1.07 | $-1.63 | · | · | |
| Shares (Basic) | 42,639,000 | 38,367,000 | 37,594,000 | 36,991,000 | 35,997,000 | 29,589,132 | 25,090,708 | · | · | |
| Shares (Diluted) | 42,639,000 | 38,367,000 | 37,594,000 | 36,991,000 | 35,997,000 | 29,589,132 | 25,090,708 | · | · | |
| EBITDA | $-110M | · | $-40M | $-96M | $-54M | $-27M | $-39M | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $57M | $174M | $339M | $396M | $182M | $109M | $44M | $80M | |
| Short-term Investments | · | $0 | $7M | $0 | · | · | · | · | · | |
| Receivables | $30M | $32M | $25M | $19M | $24M | $17M | $11M | $7M | $6M | |
| Inventory | $55M | $33M | $26M | $17M | $22M | $15M | $10M | $6M | $4M | |
| Prepaid Expense | $9M | $10M | $9M | $7M | $7M | $6M | $2M | $2M | $400.0K | |
| Current Assets | $212M | $364M | $382M | $382M | $449M | $220M | $133M | $59M | $89M | |
| PP&E (Net) | $24M | $17M | $18M | $20M | $18M | $14M | $12M | $3M | $2M | |
| PP&E (Gross) | $49M | $36M | $32M | $31M | $26M | $20M | $16M | $6M | $4M | |
| Accum. Depreciation | $26M | $19M | $14M | $11M | $8M | $6M | $4M | $3M | $2M | |
| Goodwill | $26M | $0 | $0 | $0 | $10M | $10M | $9M | $1M | · | |
| Intangibles | $132M | $4M | $6M | $8M | $11M | $14M | $14M | $2M | · | |
| Other Non-current Assets | $5M | $3M | $2M | $911.0K | $378.0K | $357.0K | $557.0K | $536.0K | $653.0K | |
| Total Assets | $419M | $407M | $429M | $434M | $502M | $271M | $170M | $68M | $92M | |
| Accounts Payable | $14M | $7M | $5M | $4M | $9M | $7M | $6M | $5M | $4M | |
| Current Liabilities | $75M | $42M | $39M | $31M | $37M | $40M | $20M | $18M | $20M | |
| Capital Leases | $29M | $33M | $37M | $41M | $20M | $22M | · | · | · | |
| Deferred Tax | · | · | · | · | $2M | $3M | $3M | $7.0K | · | |
| Other Non-current Liabilities | $8M | $800.0K | $1M | $1M | $2M | $3M | $13M | $278.0K | $144.0K | |
| Total Liabilities | $123M | $76M | $79M | $76M | $61M | $65M | $41M | $27M | $26M | |
| Long-term Debt | · | · | · | · | · | $8M | $8M | $8M | $9M | |
| Total Debt | · | · | · | · | · | $8M | $8M | · | · | |
| Common Stock | $47.0K | $39.0K | $38.0K | $37.0K | $37.0K | $32.0K | $28.0K | $22.0K | $22.0K | |
| Retained Earnings | $-577M | $-470M | $-432M | $-403M | $-305M | $-248M | $-216M | $-176M | $-144M | |
| AOCI | $-723.0K | $-3M | $-2M | $-3M | $441.0K | $2M | $-153.0K | · | · | |
| Stockholders' Equity | $296M | $330M | $350M | $358M | $443M | $206M | $129M | $41M | $66M | |
| Liabilities + Equity | $419M | $407M | $429M | $434M | $502M | $271M | $170M | $68M | $92M | |
| Shares Outstanding | 46,744,000 | 38,573,000 | 38,014,000 | 37,280,000 | 36,768,035 | 31,796,544 | 28,112,201 | 22,369,036 | 21,707,041 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $6M | $6M | $5M | $5M | $4M | $3M | $1M | $482.0K | |
| Stock-based Comp | $21M | $20M | $17M | $15M | $16M | $10M | $6M | $5M | $2M | |
| Deferred Tax | $-6M | $-286.0K | $-292.0K | $-295.0K | $-409.0K | $-491.0K | $-300.0K | $7.0K | · | |
| Amort. of Intangibles | $8M | $2M | $2M | $2M | $2M | $2M | $1M | $600.0K | $0 | |
| Restructuring | $8M | · | · | $4M | · | · | · | · | · | |
| Other Non-cash | $-1M | · | $-13M | $28M | $-11M | $-6M | $6M | · | · | |
| Operating Cash Flow | $-77M | $-35M | $-19M | $-49M | $-48M | $-23M | $-26M | $-29M | $-22M | |
| CapEx | $3M | $3M | $4M | $12M | $14M | $4M | $11M | $2M | $1M | |
| Investing Cash Flow | $50M | $-82M | $-148M | $-11M | $-6M | $-626.0K | $-25M | $-5M | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | $-20.0K | $8M | |
| Financing Cash Flow | $-708.0K | $456.0K | $3M | $2M | $271M | $96M | $116M | $-78.0K | $73M | |
| Net Change in Cash | · | · | · | $-57M | $217M | $72M | $65M | $-34M | $50M | |
| Taxes Paid | $1M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-80M | · | $-23M | $-60M | $-62M | $-27M | $-37M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.8% | · | 60.7% | 44.4% | 55.8% | 55.8% | 47.3% | · | · | |
| Operating Margin | -90.4% | · | -37.6% | -96.4% | -53.0% | -36.6% | -73.3% | · | · | |
| Net Margin | -77.1% | · | -23.2% | -91.6% | -52.2% | -36.5% | -71.9% | · | · | |
| Pretax Margin | -80.8% | · | -22.6% | -91.6% | -52.2% | -36.9% | -72.2% | · | · | |
| EBITDA Margin | -79.0% | · | -32.5% | -91.3% | -48.6% | -31.6% | -68.0% | · | · | |
| ROA | -26.0% | · | · | -22.0% | -14.9% | -14.3% | -34.4% | · | · | |
| ROE | -36.4% | · | · | -26.5% | -12.9% | -15.2% | -30.8% | · | · | |
| ROIC | -40.5% | · | · | -28.3% | -13.3% | -14.6% | -30.4% | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | · | · | 12.3 | 12.1 | 5.5 | 6.7 | · | · | |
| Quick Ratio | 0.8 | · | · | 11.6 | 11.4 | 5.0 | 6.1 | · | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.1 | · | · | |
| LT Debt / Equity | · | · | · | · | · | · | 0.1 | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | · | 0.2 | 0.3 | 0.4 | 0.5 | · | · | |
| Inventory Turnover | 1.7 | · | · | 3.4 | 2.6 | 3.0 | 3.6 | · | · | |
| Receivables Turnover | 4.5 | · | · | 5.7 | 5.4 | 6.2 | 6.4 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.33 | · | · | $9.63 | $11.99 | $6.48 | $4.58 | · | · | |
| Revenue / Share | $3.26 | · | $3.25 | $2.85 | $3.07 | $2.92 | · | · | · | |
| Cash Flow / Share | $-1.81 | · | $-0.50 | $-1.30 | $-1.33 | $-0.79 | · | · | · | |
| Cash / Share | $0.64 | · | · | $9.09 | $10.78 | $5.71 | $3.88 | · | · | |
| EPS (TTM) | $-2.51 | $-1.00 | $-0.75 | $-2.69 | $-1.54 | $-1.07 | $-1.63 | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1.1% | 12.3% | 16.0% | -4.5% | 28.0% | · | · | · | · | |
| Revenue CAGR 3Y | 9.6% | 7.5% | 12.3% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.0% | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $139M | $137M | $122M | $106M | $111M | $86M | $57M | $38M | $23M | |
| Net Income TTM | $-107M | $-39M | $-28M | $-100M | $-56M | $-32M | $-41M | $-32M | $-27M | |
| Market Cap | $297M | · | · | $516M | $1.56B | $1.48B | $664M | · | · | |
| Enterprise Value | · | · | · | · | · | $1.30B | $563M | · | · | |
| P/E | -2.5 | -10.6 | -36.5 | -5.1 | -27.5 | -43.5 | -14.5 | · | · | |
| P/S | 2.1 | · | · | 4.9 | 14.1 | 17.1 | 11.7 | · | · | |
| P/B | 1.0 | · | · | 1.4 | 3.5 | 7.2 | 5.2 | · | · | |
| P / Tangible Book | 2.2 | 1.3 | 3.0 | 1.5 | 3.7 | 8.1 | · | · | · | |
| P / Cash Flow | -3.8 | · | · | -10.7 | -32.5 | -63.3 | -25.4 | · | · | |
| P / FCF | -3.7 | · | · | -8.6 | -25.3 | -54.2 | -17.9 | · | · | |
| EV / EBITDA | · | · | · | · | · | -47.8 | -14.6 | · | · | |
| EV / FCF | · | · | · | · | · | -47.8 | -15.2 | · | · | |
| EV / Revenue | · | · | · | · | · | 15.1 | 9.9 | · | · | |
| Earnings Yield | -39.5% | -9.4% | -2.7% | -19.4% | -3.6% | -2.3% | -6.9% | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $36M | $44M | $40M | $24M | $30M | $35M | $36M | $34M | $32M | $32M | $32M | $31M | $28M | $26M | $27M | |
| Cost of Revenue | $20M | $21M | $24M | $23M | $14M | $15M | $13M | $16M | $12M | $14M | $12M | $12M | $11M | $12M | $15M | $16M | |
| Gross Profit | $13M | $16M | $20M | $17M | $10M | $15M | $22M | $20M | $22M | $19M | $19M | $19M | $19M | $16M | $11M | $10M | |
| R&D Expense | $8M | $7M | $9M | $8M | $9M | $10M | $8M | $8M | $8M | $7M | $7M | $8M | $6M | $5M | $7M | $7M | |
| SG&A Expense | $27M | $30M | $35M | $39M | $30M | $31M | $29M | $23M | $24M | $26M | $23M | $24M | $21M | $21M | $19M | $20M | |
| Operating Expenses | $62M | $57M | $45M | $55M | $47M | $41M | $37M | $32M | $33M | $34M | $33M | $32M | $28M | $27M | $36M | $48M | |
| Operating Income | $-49M | $-41M | $-25M | $-37M | $-37M | $-26M | $-15M | $-12M | $-11M | $-15M | $-14M | $-13M | $-9M | $-11M | $-25M | $-38M | |
| Other Non-op | $-239.0K | $21M | $225.0K | $-178.0K | $49.0K | $61.0K | $-358.0K | $5.0K | $-9.0K | $226.0K | $626.0K | $2M | $-214.0K | $-5.0K | $399.0K | $-235.0K | |
| Pretax Income | $-49M | $-18M | $-23M | $-36M | $-30M | $-23M | $-12M | $-8M | $-7M | $-11M | $-9M | $-7M | $-5M | $-7M | $-21M | $-36M | |
| Income Tax | $-54.0K | $-7.0K | $345.0K | $-2M | $-73.0K | $-3M | $-8.0K | $145.0K | $117.0K | $180.0K | $141.0K | $203.0K | $235.0K | $140.0K | $154.0K | $72.0K | |
| Net Income | $-49M | $-18M | $-23M | $-34M | $-30M | $-21M | $-12M | $-8M | $-7M | $-11M | $-9M | $-7M | $-6M | $-7M | $-21M | $-37M | |
| EPS (Basic) | $-1.04 | $-0.37 | $-0.48 | $-0.73 | $-0.77 | $-0.53 | $-0.30 | $-0.22 | $-0.19 | $-0.29 | $-0.23 | $-0.18 | $-0.15 | $-0.19 | $-0.58 | $-0.99 | |
| EPS (Diluted) | $-1.04 | $-0.37 | $-0.48 | $-0.73 | $-0.77 | $-0.53 | $-0.30 | $-0.22 | $-0.19 | $-0.29 | $-0.23 | $-0.18 | $-0.15 | $-0.19 | $-0.58 | $-0.99 | |
| Shares (Basic) | 47,167,000 | 46,979,000 | · | 46,060,000 | 38,893,000 | 38,718,000 | · | 38,449,000 | 38,338,000 | 38,126,000 | 37,890,000 | 37,657,000 | 37,494,000 | 37,327,000 | 37,160,000 | 37,005,000 | |
| Shares (Diluted) | 47,167,000 | 46,979,000 | · | 46,060,000 | 38,893,000 | 38,718,000 | · | 38,449,000 | 38,338,000 | 38,126,000 | 37,890,000 | 37,657,000 | 37,494,000 | 37,327,000 | 37,160,000 | 37,005,000 | |
| EBITDA | $-49M | $-36M | · | $-37M | $-37M | $-24M | · | $-12M | $-11M | $-14M | · | $-14M | $-10M | $-8M | · | $-37M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $36M | $30M | $38M | $133M | $77M | $57M | $29M | $47M | $45M | · | $201M | $330M | $329M | · | $344M | |
| Receivables | $22M | $27M | $30M | $33M | $24M | $28M | $32M | $31M | $32M | $29M | · | $24M | $24M | $23M | · | $18M | |
| Inventory | $48M | $51M | $55M | $55M | $30M | $31M | $33M | $33M | $33M | $29M | · | $20M | $18M | $17M | · | $18M | |
| Prepaid Expense | $8M | $9M | $9M | $10M | $7M | $9M | $10M | $9M | $9M | $10M | · | $9M | $7M | $7M | · | $6M | |
| Current Assets | $171M | $186M | $212M | $233M | $322M | $335M | $364M | $367M | $370M | $369M | · | $381M | $379M | $376M | · | $387M | |
| PP&E (Net) | $20M | $21M | $24M | $26M | $16M | $16M | $17M | $18M | $18M | $17M | · | $18M | $18M | $19M | · | $21M | |
| PP&E (Gross) | · | · | $49M | · | · | · | $36M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $26M | · | · | · | $19M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $0 | $27M | $26M | $23M | $0 | $7M | $0 | · | · | · | · | $0 | $0 | $0 | · | · | |
| Intangibles | $106M | $109M | $132M | $135M | $16M | $17M | $4M | $5M | $5M | $5M | · | $6M | $6M | $7M | · | $8M | |
| Other Non-current Assets | $4M | $5M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $1M | |
| Total Assets | $320M | $367M | $419M | $444M | $376M | $397M | $407M | $411M | $416M | $414M | · | $429M | $429M | $427M | · | $447M | |
| Accounts Payable | $9M | $9M | $14M | $11M | $9M | $7M | $7M | $6M | $7M | $4M | · | $5M | $3M | $3M | · | $2M | |
| Current Liabilities | $50M | $50M | $75M | $77M | $48M | $40M | $42M | $36M | $38M | $33M | · | $35M | $32M | $27M | · | $29M | |
| Capital Leases | $26M | $27M | $29M | $31M | $30M | $31M | $33M | $34M | $35M | $36M | · | $38M | $39M | $40M | · | $42M | |
| Other Non-current Liabilities | $701.0K | $883.0K | $8M | $7M | $794.0K | $822.0K | $800.0K | $956.0K | $1M | $1M | · | $1M | $1M | $1M | · | $2M | |
| Total Liabilities | $82M | $85M | $123M | $130M | $83M | $80M | $76M | $72M | $75M | $71M | · | $76M | $74M | $70M | · | $74M | |
| Common Stock | $47.0K | $47.0K | $47.0K | $47.0K | $39.0K | $39.0K | $39.0K | $39.0K | $38.0K | $38.0K | · | $38.0K | $37.0K | $37.0K | · | $37.0K | |
| Retained Earnings | $-644M | $-595M | $-577M | $-554M | $-521M | $-491M | $-470M | $-458M | $-450M | $-443M | · | $-422M | $-414M | $-408M | · | $-384M | |
| AOCI | $-1M | $-1M | $-723.0K | $-818.0K | $-928.0K | $-2M | $-3M | $-1M | $-3M | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | |
| Stockholders' Equity | $237M | $282M | $296M | $315M | $292M | $316M | $330M | $339M | $341M | $343M | $350M | $353M | $355M | $357M | $358M | $373M | |
| Liabilities + Equity | $320M | $367M | $419M | $444M | $376M | $397M | $407M | $411M | $416M | $414M | · | $429M | $429M | $427M | · | $447M | |
| Shares Outstanding | 47,135,000 | 47,061,000 | 46,744,000 | 46,683,000 | 38,873,000 | 38,801,000 | 38,573,000 | 38,475,000 | 38,398,000 | 38,288,000 | · | 37,839,000 | 37,566,000 | 37,423,981 | · | 37,093,601 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $5M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $4M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $600.0K | $600.0K | $-1M | $1M | $400.0K | · | · | · | · | · | · | · | |
| Restructuring | · | · | $400.0K | $6M | $1M | · | · | · | · | · | · | · | $0 | $-33.0K | · | $3M | |
| Other Non-cash | · | $-11M | · | · | · | $-1M | · | · | · | · | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-5M | $-18M | $-16M | $-41M | $-6M | $-14M | $-4M | $-6M | $-5M | $-20M | $-6M | $-4M | $711.0K | $-10M | $-4M | $-15M | |
| CapEx | $96.0K | $87.0K | $-98.0K | $677.0K | $777.0K | $1M | $412.0K | $851.0K | $2M | $506.0K | $2M | $1M | $811.0K | $136.0K | $1M | $4M | |
| Investing Cash Flow | $14M | $25M | $8M | $-53M | $62M | $33M | $32M | $-12M | $7M | $-109M | $-21M | $-126M | $-811.0K | $-136.0K | $-1M | $-4M | |
| Financing Cash Flow | $-527.0K | $-770.0K | $-522.0K | $150.0K | $-429.0K | $93.0K | $41.0K | $144.0K | $-328.0K | $599.0K | $201.0K | $2M | $139.0K | $551.0K | $714.0K | $407.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-18M | |
| Free Cash Flow | · | $-18M | · | · | · | $-15M | · | · | · | $-21M | · | · | · | $-10M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.5% | 42.8% | · | 42.8% | 46.2% | 54.1% | · | 56.3% | 64.7% | 57.8% | · | 56.8% | 61.7% | 59.5% | · | 41.1% | |
| Operating Margin | -150.2% | -113.6% | · | -92.8% | -151.6% | -86.9% | · | -32.8% | -31.8% | -47.3% | · | -44.0% | -30.8% | -33.1% | · | -137.4% | |
| Net Margin | -148.7% | -48.2% | · | -83.3% | -122.6% | -67.6% | · | -23.3% | · | · | · | -24.8% | -19.5% | -21.4% | · | -131.6% | |
| Pretax Margin | -148.9% | -48.2% | · | -89.5% | -122.9% | -77.2% | · | -22.9% | -21.1% | -34.2% | · | -24.1% | -18.8% | -21.0% | · | -131.3% | |
| EBITDA Margin | -150.2% | -98.2% | · | -92.8% | -151.6% | -79.7% | · | -32.8% | -31.8% | -42.5% | · | -44.0% | -30.8% | -28.1% | · | -137.4% | |
| ROA | -14.1% | -4.6% | · | -7.8% | -7.6% | -5.1% | · | -2.0% | · | · | · | -1.8% | -1.3% | -1.3% | · | -7.3% | |
| ROE | -18.5% | -5.9% | · | -10.3% | -9.5% | -6.2% | · | -2.4% | · | · | · | -2.1% | -1.6% | -1.6% | · | -8.5% | |
| ROIC | -20.8% | -14.6% | · | -11.1% | -12.7% | -7.3% | · | -3.5% | -3.3% | -4.5% | · | -4.0% | -2.8% | -2.7% | · | -9.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.7 | · | 3.0 | 6.7 | 8.3 | · | 10.1 | 9.7 | 11.3 | · | 10.8 | 11.9 | 14.0 | · | 13.5 | |
| Quick Ratio | 1.3 | 1.3 | · | 0.9 | 3.2 | 2.6 | · | 1.7 | 2.1 | 2.3 | · | 6.4 | 11.1 | 13.1 | · | 12.7 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.4 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.7 | 0.6 | 0.6 | · | 0.8 | |
| Receivables Turnover | 1.4 | 1.3 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.2 | 1.2 | · | 1.5 | 1.4 | 1.3 | · | 1.4 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.03 | $6.00 | · | $6.74 | $7.52 | $8.15 | · | $8.81 | $8.87 | $8.97 | · | $9.34 | $9.46 | $9.55 | · | $10.05 | |
| Revenue / Share | $0.70 | $0.78 | · | $0.87 | $0.63 | $0.78 | · | $0.93 | $0.90 | $0.84 | · | $0.83 | $0.83 | $0.76 | · | $0.72 | |
| Cash Flow / Share | · | $-0.39 | · | · | · | $-0.36 | · | · | · | $-0.53 | · | · | · | $-0.25 | · | · | |
| Cash / Share | $0.94 | $0.77 | · | $0.82 | $3.42 | $1.97 | · | $0.76 | $1.22 | $1.18 | · | $5.32 | $8.77 | $8.80 | · | $9.27 | |
| EPS (TTM) | $-2.62 | $-2.35 | · | $-2.33 | $-1.82 | $-1.24 | · | $-0.93 | $-0.89 | $-0.85 | · | $-1.10 | $-1.91 | $-2.49 | · | $-2.70 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $153M | $145M | · | $130M | $126M | $136M | · | $134M | $130M | $126M | · | $117M | $112M | $104M | · | $110M | |
| Net Income TTM | $-123M | $-104M | · | $-96M | $-70M | $-48M | · | $-36M | $-34M | $-32M | · | $-41M | $-71M | $-92M | · | $-99M | |
| Market Cap | $204M | $166M | · | $253M | $259M | $253M | · | $499M | $507M | $902M | · | $1.03B | $847M | $422M | · | $409M | |
| P/E | -1.6 | -1.5 | · | -2.3 | -3.7 | -5.2 | · | -13.9 | -14.8 | -27.7 | · | -24.7 | -11.8 | -4.5 | · | -4.1 | |
| P/S | 1.3 | 1.1 | · | 1.9 | 2.1 | 1.9 | · | 3.7 | 3.9 | 7.2 | · | 8.8 | 7.6 | 4.0 | · | 3.7 | |
| P/B | 0.9 | 0.6 | · | 0.8 | 0.9 | 0.8 | · | 1.5 | 1.5 | 2.6 | · | 2.9 | 2.4 | 1.2 | · | 1.1 | |
| P / Tangible Book | 1.5 | 1.1 | · | 1.6 | 0.9 | 0.9 | · | 1.5 | 1.5 | 2.7 | · | 3.0 | 2.4 | 1.2 | · | 1.1 | |
| P / Cash Flow | · | -9.1 | · | · | · | -18.2 | · | · | · | -44.7 | · | · | · | -44.4 | · | · | |
| Earnings Yield | -60.7% | -66.8% | · | -42.9% | -27.4% | -19.1% | · | -7.2% | -6.7% | -3.6% | · | -4.0% | -8.5% | -22.1% | · | -24.5% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Ricavi | $139M | $137M | $122M | · | · |
| Margine Lordo % | 46.8% | · | 60.7% | · | · |
| Margine Operativo % | -90.4% | · | -37.6% | · | · |
| Utile netto | $-107M | $-39M | $-28M | · | · |
| EPS Diluito | $-2.51 | $-1.00 | $-0.75 | · | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Rapporto corrente | 2.8 | · | · | · | · |
| Quick Ratio | 0.8 | · | · | · | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-80M | · | $-23M | · | · |
Proprietari istituzionali (13F) 144 filer · $145.5M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
144
Valore detenuto
$145.5M
Nuove posizioni
39
Posizioni chiuse
31
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 39 (+16 vs trimestre precedente) | 31 (+11 vs trimestre precedente) | 44 (-5 vs trimestre precedente) | 29 (-5 vs trimestre precedente) | -4.6M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $17.031.018 | 2.677.833 | 11,71% | Azioni |
| BlackRock, Inc. | $15.704.976 | 3.635.411 | 10,80% | Azioni |
| Blue Water Life Science Advisors, LP | $15.008.553 | 3.474.202 | 10,32% | Azioni |
| First Eagle Investment Management, LLC | $11.893.673 | 2.753.165 | 8,18% | Azioni |
| Portolan Capital Management, LLC | $8.205.011 | 1.899.308 | 5,64% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.778.782 | 1.800.644 | 5,35% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $5.801.782 | 1.343.005 | 3,99% | Azioni |
| Kent Lake PR LLC | $5.435.430 | 1.001.000 | 3,74% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $4.888.805 | 1.131.377 | 3,36% | Azioni |
| AMERIPRISE FINANCIAL INC | $4.265.671 | 987.424 | 2,93% | Azioni |
| MARSHALL WACE, LLP | $4.207.125 | 973.872 | 2,89% | Azioni |
| STATE STREET CORP | $4.027.566 | 932.307 | 2,77% | Azioni |
| Tikvah Management LLC | $2.469.118 | 571.555 | 1,70% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.114.925 | 489.566 | 1,45% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.106.432 | 487.600 | 1,45% | Azioni |
| MORGAN STANLEY | $1.934.013 | 447.688 | 1,33% | Azioni |
| JANE STREET GROUP, LLC | $1.810.296 | 419.050 | 1,24% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $1.729.737 | 400.402 | 1,19% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $1.719.314 | 397.833 | 1,18% | Azioni |
| Cubist Systematic Strategies, LLC | $1.707.290 | 314.418 | 1,17% | Azioni |
| NORTHERN TRUST CORP | $1.456.820 | 337.227 | 1,00% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.342.228 | 310.701 | 0,92% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.245.504 | 288.311 | 0,86% | Azioni |
| UBS Group AG | $1.218.145 | 281.978 | 0,84% | Azioni |
| Balyasny Asset Management L.P. | $1.123.200 | 260.000 | 0,77% | Opzione Call |
| Nuveen, LLC | $1.004.798 | 232.592 | 0,69% | Azioni |
| CITADEL ADVISORS LLC | $992.460 | 229.736 | 0,68% | Azioni |
| XTX Topco Ltd | $985.111 | 228.035 | 0,68% | Azioni |
| Point72 Asset Management, L.P. | $974.821 | 225.653 | 0,67% | Azioni |
| GOLDMAN SACHS GROUP INC | $916.082 | 212.056 | 0,63% | Azioni |
| FMR LLC | $909.940 | 210.634 | 0,63% | Azioni |
| IRONWOOD INVESTMENT MANAGEMENT LLC | $736.798 | 170.555 | 0,51% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $728.439 | 168.620 | 0,50% | Azioni |
| Invesco Ltd. | $695.032 | 160.887 | 0,48% | Azioni |
| WELLS FARGO & COMPANY/MN | $644.362 | 149.158 | 0,44% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $642.030 | 148.618 | 0,44% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $591.304 | 136.876 | 0,41% | Azioni |
| Bank of New York Mellon Corp | $569.808 | 131.900 | 0,39% | Azioni |
| TWO SIGMA ADVISERS, LP | $552.620 | 86.890 | 0,38% | Azioni |
| SCS Capital Management LLC | $518.551 | 120.035 | 0,36% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $434.000 | 100.463 | 0,30% | Azioni |
| JNB Advisors LLC | $432.250 | 65.000 | 0,30% | Azioni |
| Clarius Group, LLC | $404.011 | 62.060 | 0,28% | Azioni |
| Quadrature Capital Ltd | $346.464 | 80.200 | 0,24% | Azioni |
| Cerity Partners LLC | $337.319 | 78.083 | 0,23% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $294.736 | 68.226 | 0,20% | Azioni |
| Clearstead Advisors, LLC | $268.969 | 62.261 | 0,18% | Azioni |
| Jain Global LLC | $247.618 | 57.319 | 0,17% | Azioni |
| ALGERT GLOBAL LLC | $238.537 | 55.217 | 0,16% | Azioni |
| RHUMBLINE ADVISERS | $231.358 | 53.557 | 0,16% | Azioni |
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Kent Lake Partners LP, Kent Lake PR LLC, Benjamin Natter, Alexander G. Dickinson, Bruce Felt, Hakan Sakul ×3 depositi | 15 Luglio 2025 | 4,50% | Modifica | Campagna per il consiglio di amministrazione | SEC |
| Akoya Biosciences, Inc. ×2 depositi | 30 Aprile 2025 | 0,00% | Modifica | · | SEC |
| Quanterix Corporation ×2 depositi | 30 Aprile 2025 | 55,60% | Modifica | M&A / vendita | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 40 insider · 21 dirigenti · 21 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Everett Cunningham | President and CEO | 19 Gennaio 2026 A | · | 0 | 0 | $0 |
| Masoud Toloue | President & CEO | 15 Gennaio 2026 F | 507.310 | 0 | 0 | $0 |
| Jason F. Faessler | Chief Financial Officer | 15 Luglio 2026 A | · | 0 | 0 | $0 |
| Vandana Sriram | Chief Financial Officer | 15 Giugno 2026 M | 31.283 | 0 | 0 | $0 |
| Michael A Doyle | CFO and Treasurer | 30 Settembre 2023 F | 88.332 | 0 | 0 | $0 |
| Shawn Stetson | Interim CFO and Treasurer | 11 Maggio 2021 A | 4.712 | 0 | 0 | $0 |
| Amol Chaubal | Chief Financial Officer | 03 Maggio 2021 S | 30.222 | 0 | 0 | $0 |
| Joseph Driscoll | Chief Financial Officer | 15 Gennaio 2019 M | 4.388 | 0 | 0 | $0 |
| William Geist | Chief Operating Officer | 08 Febbraio 2021 A | 44.951 | 0 | 0 | $0 |
| James Edward Gute Jr. | Chief Commercial Officer | 15 Settembre 2026 A | · | 0 | 0 | $0 |
| Michael Francis Miller | Chief Technology Officer | 15 Settembre 2026 M | 38.452 | 0 | 0 | $0 |
| Benjamin Meadows | Chief Commercial Officer | 12 Maggio 2026 P | 3.500 | 1 | 0 | $9.695 |
| John J Fry | General Counsel & Secretary | 01 Agosto 2022 S | 37.671 | 0 | 0 | $0 |
| Kevin E Hrusovsky | Executive Chairman | 05 Luglio 2022 S | 910.249 | 0 | 0 | $0 |
| Dawn Mattoon | Sr. VP, Diagnostics | 01 Aprile 2022 S | 36.876 | 0 | 0 | $0 |
| Mark T. Roskey | SVP, Strategic Partnerships | 01 Aprile 2022 S | 22.325 | 0 | 0 | $0 |
| David C. Duffy | SVP R&D and CTO | 23 Marzo 2022 S | 54.730 | 0 | 0 | $0 |
| Amee Desjourdy | Chief Human Resource Officer | 19 Agosto 2019 A | 11.834 | 0 | 0 | $0 |
| Jackson Streeter | SVP, Corp Dev & Strategy | 17 Marzo 2019 A | 32.515 | 0 | 0 | $0 |
| Ernest Orticerio | SVP Finance and Corporate Dev | 09 Gennaio 2019 M | 48.802 | 0 | 0 | $0 |
| Bruce J Bal | VP of Ops, Service and Quality | 10 Maggio 2018 A | 5.485 | 0 | 0 | $0 |
| Ivana Magovcevic-Liebisch | Direttore | 02 Ottobre 2026 M | 15.883 | 0 | 0 | $0 |
| Scott Mendel | Direttore | 01 Ottobre 2026 A | 28.454 | 0 | 0 | $0 |
| William P Donnelly | Direttore | 01 Ottobre 2026 A | 169.365 | 2 | 0 | $286.354 |
| Jeffrey Thomas Elliott | Direttore | 19 Agosto 2026 M | 15.345 | 0 | 0 | $0 |
| Goldman Myla Lai | Direttore | 08 Luglio 2026 M | 15.041 | 0 | 0 | $0 |
| Alan Bruce Sachs | Direttore | 02 Gennaio 2026 A | 70.099 | 0 | 0 | $0 |
| Malcolm Garret Hampton | Direttore | 02 Gennaio 2026 A | 70.099 | 0 | 0 | $0 |
| Karen Flynn | Direttore | 02 Gennaio 2026 A | 57.212 | 0 | 0 | $0 |
| David R Walt | Direttore | 02 Gennaio 2026 A | 1.872.890 | 0 | 0 | $0 |
| Paul M Meister | Direttore | 02 Gennaio 2026 A | 313.253 | 0 | 0 | $0 |
| Sarah H Mcconnell | Direttore | 01 Luglio 2025 A | 60.070 | 0 | 0 | $0 |
| Martin D Madaus | Direttore | 02 Gennaio 2025 A | 36.908 | 0 | 0 | $0 |
| Laurie J Olson | Direttore | 14 Maggio 2024 S | 13.738 | 0 | 0 | $0 |
| Brian J Blaser | Direttore | 02 Gennaio 2024 A | 19.049 | 0 | 0 | $0 |
| Keith Crandell | Direttore | 03 Aprile 2023 A | 131.236 | 0 | 0 | $0 |
| Marijn E Dekkers | Direttore | 07 Giugno 2021 M | 2.270 | 0 | 0 | $0 |
| John M Connolly | Direttore | 02 Gennaio 2020 A | 9.510 | 0 | 0 | $0 |
| Douglas G. Cole | Direttore | 02 Gennaio 2019 A | 4.540 | 0 | 0 | $0 |
| bioMerieux/ADR | Proprietario del 10% | 11 Dicembre 2017 C | 2.055.632 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 15 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,67% | 44.909 SH | 02 Ottobre 2026 | Giornaliero |
| IWC · iShares Trust | 0,02% | 142.456 SH | 11 Settembre 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 93.704 SH | 02 Ottobre 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 8.458 SH | 02 Ottobre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 245.120 SH | 19 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 38.088 SH | 19 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | 0,01% | 298.897 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,00% | 20.407 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.103.537 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 12.646 SH | 03 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 500.146 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.254.850 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.970 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 111.700 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 389.677 SH | 11 Settembre 2026 | Giornaliero |
QTRX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 8 analisti
VENDI
Target mediano
$3.00
-17,6%
0 0,0%
Acquisto forte
0 0,0%
Compra
5 62,5%
Mantieni
1 12,5%
Vendi
2 25,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-10-03Target medio $3.00 -17,6%
Basso$3.00
Media$3.00
Alto$3.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| QTRX | $297M | -2.5 | 1.1% | -77.1% | -36.4% | 46.8% |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| QSI | · | · | · | · | · | · |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| NAUT | $247M | -4.1 | · | · | -34.9% | · |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | · |
| SEER | · | -1.4 | 17.0% | · | · | · |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
| CSBR | $83M | -74.5 | 4.4% | -2.0% | -30.5% | · |
| HYFT | · | · | · | -89.7% | -78.9% | 58.8% |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 10, 2026